Participants in whom 3DE analysis could not be performed were heavier, more likely to have hypertension, DM and prior CHD as well as having a poorer NT ProBNP, troponin, lipid profile and kidney function (Supplementary Table S1). This evidence concerns the gene NPPB and hypertensive disorder.